Philip Morris
000118 Conference Call with Andrew Butler, Dow Chemical, A.J. Kay, Jr., R. D. Lathaw
Fields
- Author
- Latshaw, R.D.
- Area
- PM USA/CARLSTADT
- Type
- MEMO, MEMORANDUM
- Copied
- Forsmark, F.W.
- Harris, W.B., J.R.
- Named Person
- Bujold, J.
- Butler, A.
- Kay, A.J., J.R.
- Latshaw, R.D.
- Sharrock
- Butler, A.
- Recipient (Organization)
- PM, Philip Morris
- Document File
- 2023799679/2023799822/Operations 940000 - 860000
- Author (Organization)
- PM, Philip Morris
- Request
- Stmn/R1-004
- Stmn/R1-071
- Site
- N308
- Litigation
- Stmn/Produced
- Stmn/Trial Exhibit P-11698
- Txag/Trial Exhibit P-12342
- Txag/Trial Exhibit P-14682
- Txag/Trial Exhibit P-15685
- Stmn/Selected
- Stmn/Trial Exhibit P-11698
- Master ID
- 2023799789/9807
Related Documents:- 2023799789 Dow Nicorette
- 2023799790
- 2023799791
- 2023799792
- 2023799793-9794 If You Want to Quit for Good... Your Doctor Can Help
- 2023799795 Dow Nicorette
- 2023799796-9797 Dow - Nicorette Situation
- 2023799798 Merrell Dow Pharmaceutical Meeting - 820713
- 2023799799-9800 Suspension of Dow Purchases
- 2023799801-9802 Dow - Nicorette Meeting, 841023
- 2023799804
- 2023799805
- 2023799806
- 2023799807 If You Want to Quit Smoking for Good, See Your Doctor
- Named Organization
- Dow
- Merrell Pharmaceuticals
- Natl Interagency Council on Smoking + He
- Time
- Business Week
- Merrell Pharmaceuticals
- Date Loaded
- 27 Feb 1998
- UCSF Legacy ID
- nar74e00
Document Images
PHILIP MORRIS U. S. A.
INTER-OFFICE CORRESPONDENCE
RICHMOND, VIRGINIA
To: . FILE
Frorn: . R. D. Latshaw
Date: January 22, 1985
Subject: . JANUARY 18 CONFERENCE CALL WITH ANDREW BUTLER, DOW CHEMICAL, A. J. KAY, JR.,
R. D. LATSHAW
Butler called to respond to our concerns regarding Dow's support of the
National Interagency Council on Smoking and Health voiced in A. J. Kay, Jr's
December 17th letter.
Following our October 23rd meeting with Butler and Dave Sharrock (President,
Merrell Dow Pharmaceuticals), Sharrock reviewed Merrell's funding of various
health related groups to insure Dow was not supporting purely anti-industry
associations. Based on the review, Dow has ceased all further donations
to NICSH. Dow contributed to NICSH in '83 and '84 because the Council was
research oriented at its inception, but NICSH has dri.fted towards being
purely anti-smoking. Support has been withdrawn from other organizations
such as the Non-Smoking Generation.
Dow's Corporate Affairs Department also reviewed activities with senior
management to assure that the company had no anti-cigarette industry programs
or policies at a corporate level.
Butler stated the Nicorette theme to be "if you want to quitA smoking, we
have a product". He perceived Nicorette to be a competing product which is
treated as such by Dow. Dow has no policy or dictate against the cigarette
industry.
As was indicated in our October 23rd meetings, Merrell has started adver-_
tising Nicorette in monthly publications such as Business Week and Time.
This change in promotional strategy is prompted by Merrell's introduction
of a new drug which is being pushed at the physician level by the sales
force, who were formerly promoting Nicorette. Joe Bujold, Dow's corporate
Account Manager in Richmond, has been invited to Merrell's Cincinnati head-
quarters in February to review and comment upon the new ad campaign. We
indicated displeasure with the ads.
RDL/lwk
~
cc: F. W. Forsmark ~
W. B. Harris, Jr. -N
{~~
~
~
W,
